Visigen Biotechnologies Inc is categorized under Commercial Biotechnical Research in Carlsbad, CA and active since 2000.
Visigen Biotechnologies Inc was established in 2000, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Susan Hardin at the company’s single location by writing to 1620 Faraday Avenue, Carlsbad, California CA 92008 or by phoning (631) 549-9123. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Visigen Biotechnologies Inc |
| Contact Person: | Susan Hardin |
| Address: | 1620 Faraday Avenue, Carlsbad, California 92008 |
| Phone Number: | (631) 549-9123 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Visigen Biotechnologies Inc was started in 2000 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Susan Hardin for inquiries that concern Visigen Biotechnologies Inc by calling the company number (631) 549-9123, as your correspondence is most welcome. Additionally, the physical location of the single location of Visigen Biotechnologies Inc can be found at the coordinates as well as the street address 1620 Faraday Avenue in Carlsbad, California 92008.
For its online presence, you may visit Visigen Biotechnologies Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.